Avonex (interferon beta-1a) for multiple sclerosis

January 1996

The FDA will soon approve Avonex (interferon beta-1a) for multiple sclerosis.

It's a beta-interferon...similar to Betaseron.

Both Avonex and Betaseron help reduce the frequency of relapses in patients with the relapsing-remitting form of MS. In addition, Avonex also slows the progression of the disease.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

more about using thrombolytics for acute ischemic strokes
Diabetes Bayer is finally launching Precose (acarbose)
Cardiology the recent concerns about calcium blockers decreasing survival
Cardiology new calcium channel blocker for hypertension called Sular (nisoldipine)
Oral Health some people get fewer canker sores when they switch to a toothpaste that doesn't contain sodium lauryl sulfate (SLS)
Oral Health Trental (pentoxifylline) for severe cases of recurrent canker sores
Cholesterol one cholesterol test isn't enough to diagnose a patient with hyperlipidemia
approving the antihistamine clemastine (Tavist) for cold symptoms
Hematology & Oncology limit tamoxifen (Nolvadex) use to 5 years
Hematology & Oncology Vesanoid, the first vitamin A derivative that's been approved for treating cancer
Anticoagulants ReoPro (abciximab) to inhibit blood clotting
Ritalin (methylphenidate) for ADHD
Avonex (interferon beta-1a) for multiple sclerosis
using two nicotine patches a day

Avonex (interferon beta-1a) for multiple sclerosis

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents